Scientific Highlights
Using terbium against lymphoma
Promising laboratory experiments at PSI show that radionuclide therapy with the radioactive element terbium could combat lymphoma effectively.
From coral berries to new therapies: uncovering the molecular glue mechanism of natural compounds
Researchers at the Center for Life Sciences and the Center for Scientific Computing, Theory, and Data at the Paul Scherrer Institute have identified the mechanism by which certain natural compounds interfere with cellular signaling. These ‘molecular glues’ have a therapeutic potential for the treatment of specific cancer types. Their latest study on this topic has been published in the journal Proceedings of the National Academy of Sciences of the United States of America.
Dr. Yingfang He has been honored with the Alavi-Mandell Award 2025
We congratulate Dr. Yingfang He for the excellent research work she did during her time at the Center for Radiopharmaceutical Sciences.